{
  "doc_id": "80e0d273288af7f8b8747a050c40a9f4dadea6d8622210d259688d928c752eaf",
  "chunk_entities": [
    {
      "chunk_id": "ee66687e5d404840448a7c80782ff97e",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "Immunomodulatory effects",
          "context": "Immunomodulatory effects of Sceletium tortuosum"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "Immunomodulatory effects of Sceletium tortuosum"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Trimesemine\u2122",
          "context": "Sceletium tortuosum (Trimesemine\u2122)"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic disease",
          "context": "Implications for chronic disease"
        }
      ]
    },
    {
      "chunk_id": "c5293d4c0ce3052147f3146ed9e0bef0",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium exerts significant cytoprotective effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cytoprotective effects",
          "context": "exerts significant cytoprotective effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "endotoxin",
          "context": "setting of endotoxin stimulation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Cytokine",
          "context": "Cytokine assessment indicated"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium possesses mild anti-inflammatory properties"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-inflammatory properties",
          "context": "possesses mild anti-inflammatory properties"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium may be beneficial for the attenuation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuation",
          "context": "attenuation of cytokine-induced depression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cytokine",
          "context": "cytokine-induced depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "cytokine-induced depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "systemic low-grade inflammation",
          "context": "in systemic low-grade inflammation"
        }
      ]
    },
    {
      "chunk_id": "5b9ef9184b3e5cb991a01d1704656ad1",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "ailments",
          "context": "treatment of ailments and disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "disorders",
          "context": "treatment of ailments and disorders"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-stress",
          "context": "potential anti-stress capacity"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "is Sceletium tortuosum"
        }
      ]
    },
    {
      "chunk_id": "6f223d1901bba0e5875218631aee75d7",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium extract has been shown"
        },
        {
          "entity_type": "Effect",
          "entity_name": "monoamine releasing agent",
          "context": "effectiveness as monoamine releasing agent"
        },
        {
          "entity_type": "Effect",
          "entity_name": "selective serotonin reuptake inhibitor",
          "context": "selective serotonin reuptake inhibitor"
        },
        {
          "entity_type": "Effect",
          "entity_name": "limit glucocorticoid production",
          "context": "to limit glucocorticoid production"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glucocorticoid",
          "context": "limit glucocorticoid production"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition of specific adrenal p450 enzymes",
          "context": "inhibition of specific adrenal p450 enzymes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "adrenal p450 enzymes",
          "context": "inhibition of specific adrenal p450 enzymes"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "crude Sceletium tortuosum extract"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic",
          "context": "did exhibit less anxiety behaviour"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory",
          "context": "pro-inflammatory cytokine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "interleukin-1-beta",
          "context": "interleukin-1-beta (IL-1\\beta)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-1\\beta",
          "context": "interleukin-1-beta (IL-1\\beta)"
        }
      ]
    },
    {
      "chunk_id": "6c73daeedfd85c6bf94064486059b5af",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "anti-depressive",
          "context": "anti-depressive and anxiolytic properties"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic",
          "context": "anti-depressive and anxiolytic properties"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "properties claimed for Sceletium"
        },
        {
          "entity_type": "Effect",
          "entity_name": "immunomodulation",
          "context": "exerted via immunomodulation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-inflammatory effects",
          "context": "specifically anti-inflammatory effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Trimesemine\u2122",
          "context": "Sceletium extract, Trimesemine\u2122"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory stimulus",
          "context": "acute pro-inflammatory stimulus"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Escherichia coli lipopolysaccharide",
          "context": "(Escherichia coli lipopolysaccharide, LPS)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "(Escherichia coli lipopolysaccharide, LPS)"
        },
        {
          "entity_type": "Disease",
          "entity_name": "severe acute inflammatory challenge",
          "context": "simulate severe acute inflammatory challenge"
        }
      ]
    },
    {
      "chunk_id": "8d8068530579d19a7c26ceccc8043b2a",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "Under LPS-challenged conditions"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TrimesemineTM",
          "context": "neither dose of TrimesemineTM"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory",
          "context": "pro-inflammatory cytokine concentrations"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-6",
          "context": "a lower IL-6 response"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high dose",
          "context": "after high dose treatment"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TrimesemineTM",
          "context": "with TrimesemineTM treatment"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory",
          "context": "lowering the pro-inflammatory response"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "to LPS challenge"
        }
      ]
    },
    {
      "chunk_id": "62081d0cfd4bde361c468d5a949cef39",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "anti-inflammatory",
          "context": "anti-inflammatory cytokines"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-4",
          "context": "IL-4 secretion"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-10",
          "context": "basal IL-10 secretion"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TrimesemineTM",
          "context": "TrimesemineTM supplementation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "under LPS treated conditions"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory",
          "context": "pro-inflammatory response"
        }
      ]
    },
    {
      "chunk_id": "ec6c5bf503cb29b90c9ea2b2fc6969fa",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium's potential immunomodulatory properties"
        },
        {
          "entity_type": "Effect",
          "entity_name": "immunomodulatory properties",
          "context": "Sceletium's potential immunomodulatory properties"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory cytokine production",
          "context": "investigation of pro- and anti-inflammatory cytokine production"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-inflammatory cytokine production",
          "context": "investigation of pro- and anti-inflammatory cytokine production"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "in the context of Sceletium"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "mesembrine-rich commercial Sceletium product"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "commercial Sceletium product"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inflammatory cytokine production",
          "context": "stimulus-induced inflammatory cytokine production"
        }
      ]
    },
    {
      "chunk_id": "73ea7a58778fa7acc5d9b6cbd6d66966",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "cytokines",
          "context": "major source of cytokines"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-1\u03b1",
          "context": "including, but not limited to, IL-1\u03b1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-1\u03b2",
          "context": "IL-1\u03b1, IL-1\u03b2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-6",
          "context": "IL-1\u03b2, IL-6"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-8",
          "context": "IL-6, IL-8"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-12",
          "context": "IL-8, IL-12"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-\u03b1",
          "context": "IL-12, TNF-\u03b1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "interferon-gamma",
          "context": "TNF-\u03b1, interferon-gamma (IFN-\u03b3)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MCP-1",
          "context": "IFN-\u03b3) and MCP-1"
        }
      ]
    },
    {
      "chunk_id": "49d91f70273e44e6891d12d993e069c3",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "after LPS challenge"
        },
        {
          "entity_type": "Effect",
          "entity_name": "monocyte mitochondrial viability decreased",
          "context": "monocyte mitochondrial viability decreased significantly"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TrimesemineTM",
          "context": "TrimesemineTM did not exert"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cytotoxic effects",
          "context": "did not exert cytotoxic effects"
        }
      ]
    },
    {
      "chunk_id": "0394bca466adefccd5d373d4ba9a32de",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "physiological effect of Sceletium"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TrimesemineTM",
          "context": "TrimesemineTM treatment conferred cytoprotective effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cytoprotective effects",
          "context": "conferred cytoprotective effects onto immune cells"
        },
        {
          "entity_type": "Disease",
          "entity_name": "acute endotoxin stimulation",
          "context": "presence of acute endotoxin stimulation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "maintaining XTT viability",
          "context": "thus maintaining XTT viability at control levels"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "LPS is known to activate immune cells"
        },
        {
          "entity_type": "Effect",
          "entity_name": "activate immune cells",
          "context": "LPS is known to activate immune cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Toll-like receptor 4",
          "context": "binding to Toll-like receptor 4"
        }
      ]
    },
    {
      "chunk_id": "7d51406da3c5554556511125508bfd2b",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium may protect host immune cells"
        },
        {
          "entity_type": "Effect",
          "entity_name": "protect host immune cells",
          "context": "Sceletium may protect host immune cells"
        },
        {
          "entity_type": "Effect",
          "entity_name": "rid the host of the pathogen",
          "context": "to more efficiently rid the host of the pathogen"
        },
        {
          "entity_type": "Effect",
          "entity_name": "less severe clinical symptoms",
          "context": "with less severe clinical symptoms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "nitric oxide",
          "context": "protected from the nitric oxide"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "in response to LPS"
        },
        {
          "entity_type": "Disease",
          "entity_name": "sterile inflammation",
          "context": "context of sterile inflammation"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic diseases",
          "context": "many chronic diseases are characterised"
        },
        {
          "entity_type": "Effect",
          "entity_name": "oxidative stress",
          "context": "increased levels of oxidative stress"
        },
        {
          "entity_type": "Disease",
          "entity_name": "low-grade inflammation",
          "context": "low-grade inflammation"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "potential for Sceletium to also have antioxidant capacity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antioxidant capacity",
          "context": "have antioxidant capacity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-stress effects",
          "context": "its illustrated anti-stress and anti-anxiety effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-anxiety effects",
          "context": "its illustrated anti-stress and anti-anxiety effects"
        },
        {
          "entity_type": "Disease",
          "entity_name": "modern lifestyle-associated diseases",
          "context": "effects of many modern lifestyle-associated diseases"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cytoprotective effect",
          "context": "striking cytoprotective effect of Sceletium"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "cytoprotective effect of Sceletium"
        },
        {
          "entity_type": "Effect",
          "entity_name": "modulatory effects",
          "context": "significant desired modulatory effects in the context of inflammatory signalling"
        }
      ]
    },
    {
      "chunk_id": "e8c042f34fad492e0154bb7442055dc6",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Trimesemine\u2122",
          "context": "Trimesemine\u2122 up-regulated"
        },
        {
          "entity_type": "Effect",
          "entity_name": "up-regulated basal IL-10 secretion",
          "context": "Trimesemine\u2122 up-regulated basal IL-10 secretion"
        }
      ]
    },
    {
      "chunk_id": "b2c6845dcc2b8c25dedf42d1dd31b5b2",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "this Sceletium extract"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-inflammatory",
          "context": "possesses mild anti-inflammatory potential"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "response to LPS stimulation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Trimesemine\u2122",
          "context": "presence of Trimesemine\u2122"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-10",
          "context": "up-regulation of IL-10 secretion"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-6",
          "context": "increased IL-6 production"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "induced by LPS"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Trimesemine\u2122",
          "context": "modulation by Trimesemine\u2122"
        },
        {
          "entity_type": "Disease",
          "entity_name": "pathogenic challenge",
          "context": "immune response to an acute, pathogenic challenge"
        }
      ]
    },
    {
      "chunk_id": "02dd3e80b33307755b891893b3eb7fbd",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Trimesemine\u2122",
          "context": "high-dose Trimesemine\u2122 appeared to result"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-6",
          "context": "smaller IL-6 response to LPS"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "IL-6 response to LPS"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-10",
          "context": "decreased monocyte IL-10 secretion"
        },
        {
          "entity_type": "Effect",
          "entity_name": "smaller IL-6 response",
          "context": "result in a smaller IL-6 response"
        },
        {
          "entity_type": "Effect",
          "entity_name": "decreased monocyte IL-10 secretion",
          "context": "resulted also in decreased monocyte IL-10 secretion"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high-dose",
          "context": "high-dose Trimesemine\u2122 appeared"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory cytokines",
          "context": "secrete pro-inflammatory cytokines significantly"
        },
        {
          "entity_type": "Effect",
          "entity_name": "limited inflammatory cytokine response",
          "context": "The more limited inflammatory cytokine response to LPS"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "inflammatory cytokine response to LPS"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Trimesemine\u2122",
          "context": "presence of higher dose Trimesemine\u2122"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "higher dose",
          "context": "presence of higher dose Trimesemine\u2122"
        },
        {
          "entity_type": "Effect",
          "entity_name": "limit the undesired symptomatic effects of the inflammatory hyper-response",
          "context": "may limit the undesired symptomatic effects of the inflammatory hyper-response"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inflammatory hyper-response",
          "context": "symptomatic effects of the inflammatory hyper-response to LPS"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "inflammatory hyper-response to LPS"
        },
        {
          "entity_type": "Effect",
          "entity_name": "detrimental immunosuppression",
          "context": "result of detrimental immunosuppression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "increased in response to LPS"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high dose",
          "context": "the high dose employed in the current study"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "supraphysiological dose",
          "context": "represents a supraphysiological dose"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "at least 100-fold higher than suggested daily",
          "context": "at least 100-fold higher than suggested daily"
        }
      ]
    },
    {
      "chunk_id": "47d598f50f701de28146936c8a31aa2c",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "serotonin/5-hydroxytryptamine (5-HT)",
          "context": "serotonin/5-hydroxytryptamine (5-HT) turnover"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "involved in depression"
        }
      ]
    },
    {
      "chunk_id": "e3ffacb4ef7c5c0745a5e05e89ea5afd",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "a high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "a high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Trimesemine\u2122",
          "context": "Trimesemine\u2122, beneficially modulates"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-inflammatory",
          "context": "modulates the basal inflammatory cytokine profile"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-oxidant activity",
          "context": "may affect anti-oxidant activity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cytoprotection",
          "context": "conferring significant cytoprotection"
        },
        {
          "entity_type": "Compound",
          "entity_name": "endotoxin",
          "context": "from endotoxin-associated oxidative stress damage"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "increased LPS levels"
        },
        {
          "entity_type": "Disease",
          "entity_name": "pathogenic infection",
          "context": "in pathogenic infection"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic diseases",
          "context": "in chronic diseases"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Alzheimer's disease",
          "context": "such as Alzheimer's disease"
        },
        {
          "entity_type": "Disease",
          "entity_name": "arthritis",
          "context": "arthritis (Azzouz and Silverman, 2017)"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "and depression (Zhou et al., 2018)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Trimesemine\u2122",
          "context": "role for Trimesemine\u2122"
        }
      ]
    }
  ],
  "total_entities": 150,
  "extraction_date": "2026-02-01T08:44:47.386211+00:00"
}